Hepatitis B virus (HBV) infection is a leading cause of chronic liver diseases, that spreads among individuals through blood or body fluids.
NorthX acquires Valneva’s biologics production unit
The Stockholm unit can handle biosafety level 2/2+ and BSL 3 organisms. Credit: Valneva SE. NorthX Biologics has acquired Valneva’s clinical trial manufacturing unit in Stockholm, Sweden.